Casein and whey release a range of characterised fragments during digestion and fermentation, and a few have progressed further along the evidence scale than most food peptides.
Key Takeaways
- Hydrolysis of casein releases phosphopeptides that bind calcium and may influence mineral solubility in the intestinal lumen, as well as fragments with opioid-like activity in receptor assays.
- Lactic acid bacteria used in fermented dairy generate peptides through their own proteolytic systems, which is why fermented products often contain higher levels of these fragments than the raw material.
- Distinguish receptor-binding or enzyme-inhibition assays from controlled human outcomes.
Casein-derived fragments
Hydrolysis of casein releases phosphopeptides that bind calcium and may influence mineral solubility in the intestinal lumen, as well as fragments with opioid-like activity in receptor assays. The mineral-binding behaviour is the better supported of the two.
Whey-derived fragments
Beta-lactoglobulin and alpha-lactalbumin release sequences studied for ACE-inhibitory and antimicrobial behaviour. As with most food peptides, assay evidence substantially exceeds human outcome evidence.
For related mechanism work, see exorphin opioid peptides.
Fermentation as a release route
Lactic acid bacteria used in fermented dairy generate peptides through their own proteolytic systems, which is why fermented products often contain higher levels of these fragments than the raw material. Strain selection determines which peptides appear.
What has human data
Certain casein-derived tripeptides have a modest but real body of blood-pressure literature, and this is the area where food peptides come closest to a defensible physiological claim.
Reading the literature
Distinguish receptor-binding or enzyme-inhibition assays from controlled human outcomes. The overwhelming majority of milk peptide literature is the former, and conclusions drawn from it should be stated as mechanistic rather than clinical.
Experimental Conditions and Practical Setup
Fermentation studies identify peptides by mass spectrometry after separating the hydrolysate, and the producing strain is recorded because strain-specific proteolytic systems determine which fragments appear. Enzyme inhibition is measured on the isolated peptide rather than on the whole hydrolysate, so that activity is attributed to a defined sequence.
Milk peptide classes and evidence level
| Class | Proposed activity | Evidence |
|---|---|---|
| Casein phosphopeptides | Mineral binding and solubility | Physicochemical, better supported |
| Lactotripeptides | ACE inhibition, blood pressure | Modest human data exist |
| Whey-derived fragments | ACE inhibition, antimicrobial | Mostly assay level |
| Casein opioid fragments | Receptor binding | Assay only, absorption unresolved |
Practical Notes for the Bench
- Separate enzyme-inhibition assays from controlled human outcomes.
- Note that strain selection determines which peptides fermentation produces.
- Treat mineral-binding as the better supported of the casein fragment activities.
Frequently Asked Questions
Which milk peptides have human evidence?
Certain casein-derived tripeptides have a modest body of blood-pressure literature; most others rest on assay data.
Does fermentation increase peptide levels?
Yes, because lactic acid bacteria contribute their own proteolytic activity, though the specific peptides depend on the strain.
What do casein phosphopeptides do?
They bind calcium and may influence mineral solubility in the intestinal lumen, which is their best-supported activity.
Why does the strain matter in fermented products?
Because lactic acid bacteria contribute their own proteolytic enzymes, so different strains release different peptide sets from the same starting material.
Related Reading
- exorphin opioid peptides
- bacteriocin peptides
- dietary immunomodulatory peptides
- peptide excipient compatibility
- peptide solubilisation strategies
References & Further Reading
- Samtiya M et al. Health-Promoting and Therapeutic Attributes of Milk-Derived Bioactive Peptides. Nutrients. 2022. PubMed 35893855
- Ayoub MA et al. Invited review: Camel milk-derived bioactive peptides and diabetes-Molecular view and perspectives. J Dairy Sci. 2024. PubMed 37709024
- Zong X et al. Effects of milk-derived bioactive peptide VPP on diarrhea of pre-weaning calves. Front Vet Sci. 2023. PubMed 37065247
- Peptide literature search on PubMed
- Full-text archive at PubMed Central
- USP general chapters on pharmaceutical analysis
This article summarises published research practice for laboratory professionals. It is not a guide to human use, and no claim of therapeutic benefit is made or implied.
Reviewed by Dr. Aiko Tanaka, Bioactive Peptides & Dermatological Research.